pirtobrutinib
eli lilly
['pirto', 'lymsm']
the btk inhibitor pirtobrutinib demonstrated high response rates in pretreated patients with waldenstr m macroglobulinemia, according to recent data. #lymsm #ash22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.